OTCMKTS:ALEAF - Aleafia Health Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $5.81
  • Forecasted Upside: 1,584.06 %
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.35
▼ -0.01 (-2.82%)
1 month | 3 months | 12 months
Get New Aleafia Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALEAF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALEAF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$5.81
▲ +1,584.06% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Aleafia Health in the last 3 months. The average price target is $5.81, with a high forecast of $5.81 and a low forecast of $5.81. The average price target represents a 1,584.06% upside from the last price of $0.35.

Sell

The current consensus among 1 contributing investment analysts is to sell stock in Aleafia Health.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
6/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/14/2021Cantor FitzgeraldLower Price TargetNeutral ➝ Reduce$7.06 ➝ $5.81
i
Rating by Pablo Zuanic at Cantor Fitzgerald
3/10/2021Cantor FitzgeraldInitiated CoverageNeutral
i
(Data available from 6/16/2016 forward)
Aleafia Health logo
Aleafia Health Inc. operates as an integrated cannabis health and wellness services company in Canada and internationally. It produces a portfolio of products, including dried flower and pre-rolls, as well as oil drops and capsules, oral sprays, and cannabis-infused sublingual strips. The company offers its products under the Kin Slips, Emblem, and Symbl brands. It also operates a network of 25 medical cannabis clinics under the Canabo Clinics brand name; and education centers. The company was incorporated in 2007 and is headquartered in Concord, Canada.
Read More

Today's Range

Now: $0.35
$0.34
$0.36

50 Day Range

MA: $0.40
$0.33
$0.51

52 Week Range

Now: $0.35
$0.29
$1.07

Volume

355,205 shs

Average Volume

415,282 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aleafia Health?

The following Wall Street analysts have issued stock ratings on Aleafia Health in the last twelve months: Cantor Fitzgerald.
View the latest analyst ratings for ALEAF.

What is the current price target for Aleafia Health?

1 Wall Street analysts have set twelve-month price targets for Aleafia Health in the last year. Their average twelve-month price target is $5.81, suggesting a possible upside of 1,538.5%. Cantor Fitzgerald has the highest price target set, predicting ALEAF will reach $5.81 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $5.81 for Aleafia Health in the next year.
View the latest price targets for ALEAF.

What is the current consensus analyst rating for Aleafia Health?

Aleafia Health currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ALEAF will underperform the market and that investors should sell shares of Aleafia Health.
View the latest ratings for ALEAF.

What other companies compete with Aleafia Health?

How do I contact Aleafia Health's investor relations team?

The company's listed phone number is 416-860-5665. The official website for Aleafia Health is www.aleafiahealth.com.